Austar Lifesciences (HKSE:06118) Ending Cash Position : HK$178 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Austar Lifesciences Ending Cash Position?

Austar Lifesciences's Ending Cash Position for the quarter that ended in Dec. 2024 was HK$178 Mil.

Austar Lifesciences's quarterly Ending Cash Position declined from Dec. 2023 (HK$179 Mil) to Jun. 2024 (HK$151 Mil) but then increased from Jun. 2024 (HK$151 Mil) to Dec. 2024 (HK$178 Mil).

Austar Lifesciences's annual Ending Cash Position increased from Dec. 2022 (HK$149 Mil) to Dec. 2023 (HK$179 Mil) but then declined from Dec. 2023 (HK$179 Mil) to Dec. 2024 (HK$178 Mil).

Austar Lifesciences Ending Cash Position Historical Data

The historical data trend for Austar Lifesciences's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Austar Lifesciences Ending Cash Position Chart

Austar Lifesciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

210.95

242.99

149.22

179.12

178.09

Austar Lifesciences Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															149.22	137.70	179.12	150.70	178.09

Austar Lifesciences Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Austar Lifesciences's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	174.848	+	3.245
	=	178

Austar Lifesciences's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	149.456	+	28.637
	=	178

Austar Lifesciences Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Austar Lifesciences's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Austar Lifesciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Austar Lifesciences Ltd (HKSE:06118) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

AULSF:USA

Address

No. 1018, Changning Road, Rooms 2010-2013, 20th Floor, Changning District, Shanghai, CHN

Website

https://www.austar.com.hk

Austar Lifesciences Ltd is a China-based company engaged in providing engineering solutions to pharmaceutical manufacturers and research institutes. The business activity of the group is operated through Liquid and Bioprocess Systems; Clean Room and Automation Control and Monitoring Systems; Powder and Solid Systems; Good Manufacturing Practice (GMP) Compliance Services; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment segments. It derives the majority of revenue from the Liquid and Bioprocess System segment which is involved in providing solutions in pharmaceutical and water systems to treat water. The geographical business presence of the firm is seen across China and in other countries.

Executives

True Worth Global Limited	2101 Beneficial owner
Cheung Chau Ping	2202 Interest of your spouse
Ho Kin Hung	2201 Interest of corporation controlled by you

Austar Lifesciences Headlines

No Headlines